Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date |
Reported DateTime |
Company | Symbol | Insider Relationship |
Shares Traded |
Average Price |
Total Amount |
Shares Owned |
Filing |
| 2023-03-14 Sale |
2023-03-15 5:51 pm |
Dyne Therapeutics Inc. | DYN | Scalzo Richard William See Remarks |
1,311 | $13.33 | $17,476 | 54,872 (Direct) |
View |
| 2023-03-13 Sale |
2023-03-15 5:50 pm |
Dyne Therapeutics Inc. | DYN | McNeill Jonathan See Remarks |
2,209 | $13.18 | $29,116 | 65,391 (Direct) |
View |
| 2023-03-14 Sale |
2023-03-15 5:50 pm |
Dyne Therapeutics Inc. | DYN | HIGH SUSANNA GATTI Chief Operating Officer |
1,559 | $13.33 | $20,781 | 110,476 (Direct) |
View |
| 2023-03-14 Sale |
2023-03-15 5:49 pm |
Dyne Therapeutics Inc. | DYN | Farwell Wildon Chief Medical Officer |
7,441 | $13.33 | $99,189 | 92,655 (Direct) |
View |
| 2023-03-14 Sale |
2023-03-15 5:49 pm |
Dyne Therapeutics Inc. | DYN | Brumm Joshua T See Remarks |
7,318 | $13.33 | $97,549 | 322,483 (Direct) |
View |
| 2023-03-14 Sale |
2023-03-15 5:48 pm |
Dyne Therapeutics Inc. | DYN | Beskrovnaya Oxana Chief Scientific Officer |
1,416 | $13.33 | $18,875 | 88,729 (Direct) |
View |
| 2023-01-18 Sale |
2023-01-23 08:27 am |
Dyne Therapeutics Inc. | DYN | McNeill Jonathan See Remarks |
10,000 | $14.03 | $140,300 | 136,128 (Direct) |
View |
| 2023-01-09 Sale |
2023-01-11 4:56 pm |
Dyne Therapeutics Inc. | DYN | McNeill Jonathan See Remarks |
30,150 | $11.57 | $348,836 | 67,600 (Direct) |
View |
| 2022-12-12 Purchase |
2022-12-14 4:56 pm |
Dyne Therapeutics Inc. | DYN | Rhodes Jason P Director |
934,581 | $10.7 | $10,000,017 | 9,869,483 (Indirect) |
View |
| 2022-12-12 Purchase |
2022-12-14 4:55 pm |
Dyne Therapeutics Inc. | DYN | Atlas Venture Opportunity Fund II L.P. Atlas Venture Fund XI L.P. Atlas Venture Associates XI L.P. Atlas Venture Associates XI LLC Atlas Venture Opportunity Fund I L.P. Atlas Venture Associates Opportunity I L.P. Atlas Venture Associates Opportunity I LLC Atlas Venture Associates Opportunity II LP Atlas Venture Associates Opportunity II LLC 10% Owner |
934,581 | $10.7 | $10,000,017 | 9,869,483 (Indirect Direct) |
View |
| 2022-12-12 Sale |
2022-12-13 5:06 pm |
Dyne Therapeutics Inc. | DYN | Scalzo Richard William See Remarks |
312 | $10.87 | $3,391 | 101,183 (Direct) |
View |
| 2022-12-12 Sale |
2022-12-13 5:05 pm |
Dyne Therapeutics Inc. | DYN | McNeill Jonathan See Remarks |
472 | $10.87 | $5,131 | 160,750 (Direct) |
View |
| 2022-12-12 Sale |
2022-12-13 5:05 pm |
Dyne Therapeutics Inc. | DYN | HIGH SUSANNA GATTI Chief Operating Officer |
751 | $10.87 | $8,163 | 181,035 (Direct) |
View |
| 2022-12-12 Sale |
2022-12-13 5:04 pm |
Dyne Therapeutics Inc. | DYN | Farwell Wildon Chief Medical Officer |
628 | $10.87 | $6,826 | 156,096 (Direct) |
View |
| 2022-12-12 Sale |
2022-12-13 5:04 pm |
Dyne Therapeutics Inc. | DYN | Brumm Joshua T See Remarks |
3,322 | $10.87 | $36,110 | 551,801 (Direct) |
View |
| 2022-12-12 Sale |
2022-12-13 5:03 pm |
Dyne Therapeutics Inc. | DYN | Beskrovnaya Oxana Chief Scientific Officer |
680 | $10.87 | $7,392 | 153,145 (Direct) |
View |
| 2022-10-07 Sale |
2022-10-11 09:00 am |
Dyne Therapeutics Inc. | DYN | Brumm Joshua T See Remarks |
210,000 | $12.52 | $2,629,522 | 1,080,421 (Direct) |
View |
| 2022-09-20 Sale |
2022-09-21 4:09 pm |
Dyne Therapeutics Inc. | DYN | Scalzo Richard William See Remarks |
840 | $13.7 | $11,508 | 25,495 (Direct) |
View |
| 2022-09-20 Sale |
2022-09-21 4:08 pm |
Dyne Therapeutics Inc. | DYN | McNeill Jonathan See Remarks |
1,246 | $13.7 | $17,070 | 58,222 (Direct) |
View |
| 2022-09-20 Sale |
2022-09-21 4:08 pm |
Dyne Therapeutics Inc. | DYN | HIGH SUSANNA GATTI Chief Operating Officer |
2,629 | $13.7 | $36,017 | 68,786 (Direct) |
View |
| 2022-09-20 Sale |
2022-09-21 4:07 pm |
Dyne Therapeutics Inc. | DYN | Brumm Joshua T See Remarks |
11,836 | $13.7 | $162,153 | 204,623 (Direct) |
View |
| 2022-09-20 Sale |
2022-09-21 4:07 pm |
Dyne Therapeutics Inc. | DYN | Beskrovnaya Oxana Chief Scientific Officer |
1,413 | $13.7 | $19,358 | 50,825 (Direct) |
View |
| 2022-09-15 Sale |
2022-09-15 5:30 pm |
Dyne Therapeutics Inc. | DYN | Scalzo Richard William See Remarks |
326 | $14.05 | $4,580 | 26,335 (Direct) |
View |
| 2022-09-15 Sale |
2022-09-15 5:28 pm |
Dyne Therapeutics Inc. | DYN | Farwell Wildon Chief Medical Officer |
658 | $14.05 | $9,245 | 64,724 (Direct) |
View |
| 2022-09-15 Sale |
2022-09-15 5:27 pm |
Dyne Therapeutics Inc. | DYN | McNeill Jonathan See Remarks |
494 | $14.05 | $6,941 | 59,468 (Direct) |
View |
| 2022-09-15 Sale |
2022-09-15 5:26 pm |
Dyne Therapeutics Inc. | DYN | HIGH SUSANNA GATTI Chief Operating Officer |
786 | $14.05 | $11,043 | 71,415 (Direct) |
View |
| 2022-09-15 Sale |
2022-09-15 5:25 pm |
Dyne Therapeutics Inc. | DYN | Brumm Joshua T See Remarks |
3,480 | $14.05 | $48,894 | 216,459 (Direct) |
View |
| 2022-09-15 Sale |
2022-09-15 5:24 pm |
Dyne Therapeutics Inc. | DYN | Beskrovnaya Oxana Chief Scientific Officer |
712 | $14.05 | $10,004 | 52,238 (Direct) |
View |
| 2022-07-06 Sale |
2022-07-06 6:18 pm |
Dyne Therapeutics Inc. | DYN | Brumm Joshua T See Remarks |
10,963 | $8.24 | $90,335 | 452,256 (Direct) |
View |
| 2022-06-14 Sale |
2022-06-15 8:05 pm |
Dyne Therapeutics Inc. | DYN | Scalzo Richard William See Remarks |
333 | $4.95 | $1,648 | 26,661 (Direct) |
View |
| 2022-06-14 Sale |
2022-06-15 8:04 pm |
Dyne Therapeutics Inc. | DYN | McNeill Jonathan See Remarks |
504 | $4.95 | $2,495 | 59,962 (Direct) |
View |
| 2022-06-14 Sale |
2022-06-15 8:03 pm |
Dyne Therapeutics Inc. | DYN | HIGH SUSANNA GATTI Chief Operating Officer |
802 | $4.95 | $3,970 | 72,201 (Direct) |
View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date |
Reported DateTime |
Exercisable Expiration |
Company | Symnbol | Insider Relationship |
Shares Traded |
Conversion Price |
Shares Owned |
Filing |
| 2023-01-18 Exercise |
2023-01-23 08:27 am |
N/A N/A |
Dyne Therapeutics Inc. | DYN | McNeill Jonathan See Remarks |
10,000 | $0.73 | 136,128 (Direct) |
View |
| 2023-01-18 Exercise |
2023-01-23 08:27 am |
N/A 2029-02-25 |
Dyne Therapeutics Inc. | DYN | McNeill Jonathan See Remarks |
10,000 | $0 | 136,128 (Direct) |
View |
| 2022-12-09 Option Award |
2022-12-13 5:06 pm |
N/A 2032-12-08 |
Dyne Therapeutics Inc. | DYN | Scalzo Richard William See Remarks |
76,000 | $0 | 101,183 (Direct) |
View |
| 2022-12-09 Option Award |
2022-12-13 5:05 pm |
N/A 2032-12-08 |
Dyne Therapeutics Inc. | DYN | McNeill Jonathan See Remarks |
103,000 | $0 | 160,750 (Direct) |
View |
| 2022-12-09 Option Award |
2022-12-13 5:05 pm |
N/A 2032-12-08 |
Dyne Therapeutics Inc. | DYN | HIGH SUSANNA GATTI Chief Operating Officer |
113,000 | $0 | 181,035 (Direct) |
View |
| 2022-12-09 Option Award |
2022-12-13 5:04 pm |
N/A 2032-12-08 |
Dyne Therapeutics Inc. | DYN | Farwell Wildon Chief Medical Officer |
92,000 | $0 | 156,096 (Direct) |
View |
| 2022-12-09 Option Award |
2022-12-13 5:04 pm |
N/A 2032-12-08 |
Dyne Therapeutics Inc. | DYN | Brumm Joshua T See Remarks |
366,000 | $0 | 551,801 (Direct) |
View |
| 2022-12-09 Option Award |
2022-12-13 5:03 pm |
N/A 2032-12-08 |
Dyne Therapeutics Inc. | DYN | Beskrovnaya Oxana Chief Scientific Officer |
103,000 | $0 | 153,145 (Direct) |
View |
| 2022-10-07 Exercise |
2022-10-11 09:00 am |
N/A N/A |
Dyne Therapeutics Inc. | DYN | Brumm Joshua T See Remarks |
210,000 | $1.03 | 1,080,421 (Direct) |
View |
| 2022-10-10 Gift |
2022-10-11 09:00 am |
N/A N/A |
Dyne Therapeutics Inc. | DYN | Brumm Joshua T See Remarks |
15,500 | $0 | 1,080,421 (Direct) |
View |
| 2022-10-07 Exercise |
2022-10-11 09:00 am |
N/A 2030-01-05 |
Dyne Therapeutics Inc. | DYN | Brumm Joshua T See Remarks |
210,000 | $0 | 1,080,421 (Direct) |
View |
| 2022-07-11 Option Award |
2022-07-13 4:38 pm |
N/A 2032-07-10 |
Dyne Therapeutics Inc. | DYN | Scalzo Richard William See Remarks |
55,000 | $0 | 55,000 (Direct) |
View |
| 2022-07-05 Option Award |
2022-07-06 6:23 pm |
N/A 2030-07-30 |
Dyne Therapeutics Inc. | DYN | Stehman-Breen Catherine Director |
7,222 | $0 | 7,222 (Direct) |
View |
| 2022-07-05 Option Award |
2022-07-06 6:23 pm |
N/A 2030-07-30 |
Dyne Therapeutics Inc. | DYN | Scalzo Richard William See Remarks |
17,333 | $0 | 17,333 (Direct) |
View |
| 2022-07-05 Option Award |
2022-07-06 6:21 pm |
N/A 2030-07-30 |
Dyne Therapeutics Inc. | DYN | McNeill Jonathan See Remarks |
21,666 | $0 | 21,666 (Direct) |
View |
| 2022-07-05 Option Award |
2022-07-06 6:21 pm |
N/A 2030-07-30 |
Dyne Therapeutics Inc. | DYN | Lubner David Charles Director |
7,222 | $0 | 7,222 (Direct) |
View |
| 2022-07-05 Option Award |
2022-07-06 6:20 pm |
N/A 2030-07-30 |
Dyne Therapeutics Inc. | DYN | Klein Lawrence Otto Director |
7,222 | $0 | 7,222 (Direct) |
View |
| 2022-07-05 Option Award |
2022-07-06 6:19 pm |
N/A 2030-07-30 |
Dyne Therapeutics Inc. | DYN | HIGH SUSANNA GATTI Chief Operating Officer |
36,219 | $0 | 36,219 (Direct) |
View |
| 2022-07-05 Option Award |
2022-07-06 6:18 pm |
N/A 2030-07-30 |
Dyne Therapeutics Inc. | DYN | Brumm Joshua T See Remarks |
256,435 | $0 | 452,256 (Direct) |
View |
| 2022-07-05 Option Award |
2022-07-06 6:17 pm |
N/A 2030-07-30 |
Dyne Therapeutics Inc. | DYN | Beskrovnaya Oxana Chief Scientific Officer |
23,477 | $0 | 23,477 (Direct) |
View |